CJC-1295 no DAC 10mg
€ 89,00
CJC-1295 no DAC 10 mg – Grail Formula Quality — researched and verified in collaboration with Liquilabs s.r.o. Czechia. Analytical testing confirms above 99.8 percent purity assay content of 10.88 mg no detectable heavy metals microbial contamination not detected and endotoxin below 0.001 EU per mg. Supplied as a 10 mg lyophilized peptide with full COA traceability and independent verification. Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.
For research use only – not for human or veterinary use.
Product Overview
CJC-1295 no DAC is a research peptide belonging to the growth-hormone releasing factor group. This lyophilized 10 mg peptide is evaluated in controlled laboratory environments for its relevance to pulsatile GH-axis signalling and related biochemical pathways. Analytical verification confirms assay content, identity and purity for reliable scientific modelling.
Peptide Overview
MOD GRF 1-29 (CJC-1295 no DAC) has been studied across research groups between 2010 and 2025 for its short-acting interaction with the growth-hormone axis. Its defined half-life, structure and receptor affinity allow researchers to evaluate GH-modulating factors under well-controlled laboratory settings.
Historical Background and Scientific Context
From 2012 to 2025 the scientific interest in GRF-based peptides increased significantly. Laboratories explored the peptide’s pulsatile GH modulation, pituitary signalling behaviour and biochemical characteristics. CJC-1295 no DAC became a commonly used compound for examining acute GH-release pathways and comparative modelling versus long-acting analogues.
Mechanistic Focus in Research
- Evaluation of short-acting GH-axis signalling
- Receptor-interaction modelling with growth-hormone releasing pathways
- In-vitro studies related to pituitary response mechanisms
- Comparative analysis with long-acting CJC-1295 derivatives
- Structure-function profiling of GRF-based peptides
Analytical Verification (COA)
Independent Liquilabs analysis confirms full analytical validation for Batch GF102025049. Key results include:
- Purity: above 99.8 percent :contentReference[oaicite:1]{index=1}
- Assay Content: 10.88 mg :contentReference[oaicite:2]{index=2}
- Identification – Retention Time: 0.994 :contentReference[oaicite:3]{index=3}
- Identification – Spectrum: 997 :contentReference[oaicite:4]{index=4}
- Endotoxins: below 0.001 EU per mg :contentReference[oaicite:5]{index=5}
- Microbial Growth: not detected for aerobic count, yeast or mold :contentReference[oaicite:6]{index=6}
- Heavy Metals: not detected including arsenic cadmium lead mercury nickel cobalt vanadium :contentReference[oaicite:7]{index=7}
All analytical values were obtained through validated chromatographic, spectroscopic and microbiological procedures ensuring transparent documentation and traceability.
Research Applications
- GH-axis pathway modelling
- Pituitary response and biochemical signalling evaluation
- Comparative GRF-peptide studies
- Cellular modelling involving pulsatile GH modulation
- In-vitro biochemical experiments
Grail Formula Quality
Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.
When You Choose Grail Formula…
Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.
Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation
- Supplied to another party for human investigational use
- Verified and analysed with Liquilabs s.r.o. Czechia
- Above 99.8 percent purity with validated assay content
- No detectable heavy metals or microbial contamination
- Endotoxin below 0.001 EU per mg
- Batch GF102025049 – Published October 2025
- EU shipments include bacteriostatic water
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
